LENZ

LENZ

USD

LENZ Therapeutics Inc. Common Stock

$28.050+1.120 (4.159%)

Preço em tempo real

Healthcare
Biotecnologia
Estados Unidos

Gráfico de preços

Loading Chart...

Métricas-chave

Métricas de mercado
Fundamentos da empresa
Estatísticas de negociação

Métricas de mercado

Abertura

$26.930

Máximo

$28.400

Mínimo

$26.790

Volume

0.68M

Fundamentos da empresa

Capitalização de mercado

849.1M

Setor

Biotecnologia

País

United States

Estatísticas de negociação

Volume médio

0.80M

Bolsa de valores

NMS

Moeda

USD

Faixa de 52 semanas

Mínimo $16.535Atual $28.050Máximo $50.4

Notícias relacionadas

GlobeNewswire

LENZ Therapeutics to Report Third Quarter 2025 Financial Results and Recent Corporate Highlights on November 5, 2025

SAN DIEGO, Oct. 29, 2025 (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. (NASDAQ:LENZ), a pharmaceutical company focused on the commercialization of VIZZ™ (aceclidine ophthalmologic solution) 1.44%, the first and

Ver mais
LENZ Therapeutics to Report Third Quarter 2025 Financial Results and Recent Corporate Highlights on November 5, 2025
Analyst Upgrades

Piper Sandler Maintains Overweight on LENZ Therapeutics, Raises Price Target to $67

Piper Sandler analyst Biren Amin maintains LENZ Therapeutics with a Overweight and raises the price target from $51 to $67.

Ver mais
Piper Sandler Maintains Overweight on LENZ Therapeutics, Raises Price Target to $67